| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6090410 | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Dec, 2012
(11 years ago) | |
| US5681590 | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Dec, 2012
(11 years ago) | |
| US5358941 | ORGANON LLC | Dry mix formulation for bisphosphonic acids with lactose |
Dec, 2012
(11 years ago) | |
|
US6090410 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Jun, 2013
(10 years ago) | |
|
US5358941 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids with lactose |
Jun, 2013
(10 years ago) | |
|
US5681590 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Jun, 2013
(10 years ago) | |
| US5994329 | ORGANON LLC | Method for inhibiting bone resorption |
Jul, 2018
(5 years ago) | |
|
US5994329 (Pediatric) | ORGANON LLC | Method for inhibiting bone resorption |
Jan, 2019
(5 years ago) | |
Fosamax Plus D is owned by Organon Llc.
Fosamax Plus D contains Alendronate Sodium; Cholecalciferol.
Fosamax Plus D has a total of 8 drug patents out of which 8 drug patents have expired.
Expired drug patents of Fosamax Plus D are:
- US6090410
- US5681590
- US5358941
- US6090410*PED
- US5358941*PED
- US5681590*PED
- US5994329
- US5994329*PED
Fosamax Plus D was authorised for market use on 07 April, 2005.
Fosamax Plus D is available in tablet;oral dosage forms.
Fosamax Plus D can be used as treatment of osteoporosis in post menopausal women and/or the treatment to increase bone mass in men with osteoporosis.
The generics of Fosamax Plus D are possible to be released after 17 January, 2019.
Drugs and Companies using ALENDRONATE SODIUM; CHOLECALCIFEROL ingredient
Market Authorisation Date: 07 April, 2005
Treatment: Treatment of osteoporosis in post menopausal women and/or the treatment to increase bone mass in men with osteoporosis
Dosage: TABLET;ORAL
FOSAMAX PLUS D family patents
